CBL & Associates Properties enters the second week of June with short sellers paring positions and its sole analyst coverage nudging targets higher — a modest but consistent positive signal for a mall REIT trading well below consensus.
Short sellers have been quietly stepping back from this name. Short interest dropped 15% in a single session on June 9, falling to 2.3% of the free float — down 25% over the past month and the lowest level in the 30-day window tracked here. That's not an extreme level to begin with, and the retreat matters less for squeeze mechanics than for what it signals about conviction: bears who held through the stock's 5% monthly gain are now covering rather than adding. Borrow conditions fully support the exit — cost to borrow has slumped to 0.43%, roughly half where it stood four weeks ago, and availability is vast at nearly 4,900% of short interest. There is no friction in the lending market whatsoever.
Options positioning tells a more defensive story, and that contrast is worth naming. The put/call ratio has climbed to 2.64, approaching its 52-week high of 2.83 and running well above the 20-day average of 2.15. That PCR level would be alarming in most contexts, but CBL's options market is thin enough that the absolute ratio needs careful interpretation — the z-score of 0.97 suggests the move is elevated but not extreme by historical standards for this ticker. Still, the jump in put protection since mid-May (when the PCR was running closer to 1.2) coincides with the stock's run from the $45 area toward $50, suggesting some holders are hedging recent gains ahead of the August 7 earnings date.
The analyst picture is unusually clean for a REIT of this size: there is effectively one covering voice. Ladenburg Thalmann's Floris Van Dijkum raised his target to $55 this morning — his third upward revision since initiating at $45 in December — while maintaining a Buy rating. The stock at $49.76 now trades at a roughly 10% discount to that target. The mean price target of $57.50 from the snapshot implies more upside, but with a single active analyst the consensus figure carries limited statistical weight. Factor scores add a useful independent read: the analyst recommendation differential ranks in the 99th percentile, reflecting how far the buy rating sits above peer average sentiment — an unusual signal when it comes from a single source.
Institutional flow has one standout feature worth flagging. Canyon Capital Advisors, listed as a main shareholder, sold 1.05 million shares on May 22 for approximately $48.8 million — a meaningful block disposal at around $46.44 per share. The stock has since pushed higher to nearly $50, suggesting the sell did not find sustained follow-through to the downside. Brookfield trimmed by 364,000 shares in Q1, while BlackRock and State Street both added in the most recent filings. CFO Ben Jaenicke sold roughly $315,000 of stock in early June at prices just under $49 — small in absolute terms but worth noting given the proximity to current levels.
CBL's nearest peers had a strong week. SKT and MAC each gained close to 10%, while SPG added 4% — all outpacing CBL's 2.6% weekly gain. The relative lag is modest, but the pattern from a recent note noting CBL's prior resilience has partially reversed. With the next earnings print on August 7 and the stock testing the upper end of its recent range near $50, the key question for the weeks ahead is whether the short covering seen this week reflects a genuine reassessment of the operating story or simply profit-taking by bears who entered at higher short interest levels last month.
See the live data behind this article on ORTEX.
Open CBL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
